1Wilcoek GK, Ballard CG, Cooper JA, et al. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies[J]. J Clin Psychiatry, 2008,69 (3) : 341-348. 被引量：1
3Salzman C, Jeste DV, Meyer RE, et al. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options. Clinical trials methodlogy, and policy[J]. J Clin Psychiatry, 2008,69 (6) : 889- 898. 被引量：1
4Seow D,Gauthier S. Pharmacotherapy of alzheimer disease[J]. Can J Psychiatry,2007,52(10) :620-629. 被引量：1
5Lavretsky H, Nguyen LH. Innovations: geriatric psychiatry: diagnosis and treatment of neuropsychiatric symptoms in Alzheimer's disease[J]. Psychiatr Serv, 2006,57 (5) : 617-619. 被引量：1
6Herrmann N, Lanctot KL. Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease[J]. Can J Psychiatry, 2007,52(10) : 630-646. 被引量：1
7Xu H, Wang H, Zhuang L, et al. Demonstration of an antioxidative stress mechanism of quetiapine: implications for the treatment of Alzheimer's disease[J]. IFEBS J, 2008,275 (14) : 3718-3728. 被引量：1
8Savaskan E, Schnitzler C, Schroder C, et al. Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs quetiapine [J]. Int J Neuropsyehopharmaeol,2006,9(5) :507-516. 被引量：1
9de Deyn P, Jeste DV, Swanink R, et al. Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study [ J ]. J Clin Psychopharmaeol, 2005,25 (5): 463-467. 被引量：1
10Mauri M, Mancioli A, Rebeechi V, et al. Amisulpride in the treatment of behavioural disturbanees among patients with moderate to severe Alzheimer's disease[J]. Aeta Neurol Scand, 2006,114(2) : 97-101. 被引量：1
